Do we need new scales for assessing the risk of thromboembolic events and bleeding for patients with chronic kidney disease?

DOI: https://doi.org/10.31450/ukrjnd.4(68).2020.10
Keywords: Chronic kidney disease, risk scale, thromboembolic events, bleeding.

Abstract

Chronic kidney disease (CKD) is a global health problem. Patients with CKD have an increased risk of thromboembolic complications and bleeding.

It remains difficult to determine the benefits and risks of antiplatelet and anticoagulant therapy in patients with CKD, so an individualized risk assessment of each patient should be mandatory.

To date, there are no specialized scales for assessing the risk of thromboembolic events and bleeding, which are focused on patients with CKD and take into account all the features of the course of CKD and the specific factors of their occurrence.

In this work, we decided to conduct a detailed assessment of the accuracy of the currently accepted risk scales for thromboembolic events and bleeding in patients with CKD.

Downloads

Download data is not yet available.

References

Kolesnyk M. Innovative directions of CKD prevention and treatment. Ukr J Nephr Dial. 2019; 1 (61): 3-12. doi: 10.31450 / ukrjnd.1 (61) .2019.01.

Stepanova N, Burdeyna O. Association of dyslipidemia with peritoneal dialysis technique survival. Open Access Maced J Med Sci. 2019; 7(15): 2467–2473. doi:10.3889/oamjms.2019.664.

Christiansen CF, Schmidt M, Lamberg AL. et al. Kidney disease and risk of venous thromboembolism: a nationwide population-based case-control study. J Thromb Haemost. 2014; 12: 1449-1454. doi: 10.1111/jth.12652. Epub 2014 Jul 29.

Pavord S, Myers B. Bleeding and thrombotic complications of kidney disease. Blood Rev. 2011; 25: 271-278. doi: 10.1016 / j.blre.2011.07.001.

Aursulesei V, Costache I. Anticoagulation in chronic kidney disease: from guidelines to clinical practice. Clinical Cardiology. 2019; 42: 774–782. doi: 10.1002/clc.23196.

Baber U, Howard VJ, Halperin JL. et al. Association of chronic kidney disease with atrial fibrillation among adults in the United States: reasons for geographic and racial differences in stroke (REGARDS) study. Circ. Arrhythm. Electrophysiol. 2011; 4: 26–32. doi: 10.1161/CIRCEP.110.957100. 

Gutierrez O. Risks of anticoagulation in patients with chronic kidney disease and atrial fibrillation: More than just bleeding? Res Pract Thromb Haemost. 2019; 3: 147–148. doi: 10.1002/rth2.12188.

Molnar A, Sood M. Predicting in a predicament: stroke and hemorrhage risk prediction in dialysis patients with atrial fibrillation. Semin. Dial. 2018; 31: 37–47. doi: 10.1111/sdi.12637. 

Abumuaileq RR, Abu-Assi E. et al. Comparison between CHA2DS2-VASc and the new R2CHADS2 and ATRIA scores at predicting thromboembolic event in nonanticoagulated and anticoagulated patients with non-valvular atrial fibrillation. BMC Cardiovasc. Disord. 2015;15:156. doi: 10.1186/s12872-015-0149-3.

Fu S, Zhou S, Luo L, Ye P. R2(GFR)CHADS2 and R2(GFR)CHA2DS2VASc schemes improved the performance of CHADS2 and CHA2DS2VASc scores in death risk stratification of Chinese older patients with atrial fibrillation. Clin. Interv. Aging. 2017; 12: 1233–1238. doi: 10.2147/CIA.S138405.

Zhu W, Fu L. et al. Meta-analysis of ATRIA versus CHA2DS2-VASc for predicting stroke and thromboembolism in patients with atrial fibrillation. Int. J. Cardiol. 2017; 227: 436–442. doi: 10.1016/j.ijcard.2016.11.015.

Lin WY, Lin YJ, Chung FP, Chao TF. et al. Impact of renal dysfunction on clinical outcome in patients with low risk of atrial fibrillation. Circ. J. 2014; 78 (4): 853–858. doi: 10.1253/circj.cj-13-1246. Epub 2014 Feb 13.

Pisters R, Lane D, Nieuwlaat R. et al. A novel user-friendly score (HAS-BLED) to assess1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010; 138 ( 5 ): 1093-1100. doi: 10.1378/chest.10-0134.

Fang MC, Go AS, Chang Y. et al. A new risk scheme to predict warfarin-associated hemorrhage: the ATRIA (anticoagulation and risk factors in atrial fibrillation) study. J. Am. Coll. Cardiol. 2011; 58: 395–401. doi: 10.1016/j.jacc.2011.03.031.

Molnar AO, Bota SE, Garg AX. et al. The risk of major hemorrhage with CKD. J. Am. Soc. Nephrol. 2016; 27 (9): 2825–2832. doi: 10.1681/ASN.2015050535.

O'Brien EC, Simon DN. The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation, Eur. Heart J. 2015; 36 (46): 3258–3264. doi: 10.1093/eurheartj/ehv476.

Suzuki M, Matsue Y, Nakamura R, Matsumura A, Hashimoto Y. Improvement of HAS-BLED bleeding score predictive capability by changing the definition of renal dysfunction in Japanese atrial fibrillation patients on anticoagulation therapy. Journal of Cardiology; 64 (2014): 482–487. doi: 10.1016/j.jjcc.2014.03.006.

Ocak G, Rook M, Ake R. et al. Chronic kidney disease and bleeding risk in patients at high cardiovascular risk: a cohort study. Journal of Thrombosis and Haemostasis. 2017; 16: 65–73. doi: 10.1111/jth.13904.

Massicotte-Azarniouch D, Eddeen A, Lazo A. et al. Risk of Venous Thromboembolism in Patients by Albuminuria and Estimated GFR. Am J Kidney Dis. 2017; 70(6): 826-833. http://dx.doi.org/10.1053/j.ajkd.2017.07.003.

Sandsmark DK. Proteinuria, but not eGFR, predicts stroke risk in chronic kidney disease: chronic renal insufficiency cohort study. Stroke. 2015; 46: 2075–2080. doi: 10.1161/STROKEAHA.115.009861.

Mora S, Goicoechea M, Torres E. et al. Cardiovascular risk prediction in chronic kidney disease patients. Nefrologia. 2017; 37(3): 293–300. doi: 10.1016/j.nefro.2016.10.002.

Soliman EZ, Prineas RJ, Go AS. et al. Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC). Am. Heart J. 2010; 159: 1102–1107. doi: 10.1016/j.ahj.2010.03.027.

Stehouwer CD, Smulders YM. Microalbuminuria and risk for cardiovascular disease: analysis of potential mechanisms. J. Am. Soc. Nephrol. 2006; 17: 2106–2111. doi: 10.1681/ASN.2005121288.

Lee A. et al. Association of Hb concentration and its change with cardiovascular and all cause mortality. J. Am. Heart Assoc. 2018; 7 (3): pii: e007723. doi: 10.1161/JAHA.117.007723.

Ishigami J. et al. Hemoglobin, albuminuria, and kidney function in cardiovascular risk: the ARIC (Atherosclerosis Risk in Communities) Study. J. Am. Heart Assoc. 2018; 7(2): pii: e007209. doi: 10.1161/JAHA.117.007209.

Kidney Disease, Improving global outcomes (KDIGO) Anemia Work Group. KDIGO Clinical practice guideline for anemia in chronic kidney disease. Kidney Int. Suppl. 2012; 2: 279–335. doi:10.1038/kisup.2012.45.

Stepanova NM, Kolesnyk MO, Novakivskyi VV, Loboda OM, Snisar LM, Shifris IM. Dose-dependent effect of continuous erythropoietin receptor activator on cardiac autonomic nervous activity and cardiovascular events in patients treated with online hemodiafiltration. Zaporozhye Medical Journal. 2019; 3(114): 346-354. doi: 10.14739/2310-1210.2019.3.169112.

Koulouridis J, Alfayez M, Trikalinos TA, Balk EM, Jaber BL. Dose of erythropoiesisstimulating agents and adverse outcomes in CKD: a metaregression analysis. Am. J. Kidney Dis. 2013; 61 (1): 44–56. doi: 10.1053/j.ajkd.2012.07.014.

Abramson JL. et al. Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC Study. Kidney Int. 2003; 64: 610–615. doi: 10.1046/j.1523-1755.2003.00109.x.

Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group, KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int. Suppl. 2012; 2: 337–414. doi:10.1038/kisup.2012.47.

Johannes FE Mann, Alfred K. Cheung. KDIGO Hypertension Guideline. ASN Kidney News. 2020; Vol.12, №1: 19. Available from: https://www.kidneynews.org/kidney-news/special-sections/kdigo-guidelines/kdigo-hypertension-guideline.


Abstract views: 295
PDF Downloads: 18867
Published
2020-09-11
How to Cite
Mykhaloiko, I., & Dudar, I. (2020). Do we need new scales for assessing the risk of thromboembolic events and bleeding for patients with chronic kidney disease?. Ukrainian Journal of Nephrology and Dialysis, (4(68), 67-73. https://doi.org/10.31450/ukrjnd.4(68).2020.10
Issue
No 4(68) (2020): Ukrainian Journal of Nephrology and Dialysis
Section
Nephrology School